Abstract:Objective: This study explored the ability of microRNA-135a (miR-135a) to influence cell proliferation, migration, invasion, apoptosis and tumor angiogenesis through the IGF-1/PI3K/Akt signaling pathway in non-small cell lung cancer (NSCLC). Methods: NSCLC tissues and adjacent normal tissues were collected from 138 NSCLC patients. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression levels of miR-135a and IGF-1, PI3K, Akt, VEGF, bFGF and IL-8 mRNA; western blotting was used to determine the expression levels of IGF-1, PI3K and Akt protein; and enzyme-linked immunosorbent assay (ELISA) was used to analyze the expression levels of VEGF, bFGF and IL-8 protein. Human NSCLC cell lines (A549, H460, and H1299) and the human bronchial epithelial cell line (HBE) were selected. A549 cells were assigned to blank, negative control (NC), miR-135a mimics, miR-135a inhibitors, IGF-1 siRNA and miR-135a inhibitors + IGF-1 siRNA groups. The following were performed: an MTT assay to assess cell proliferation, a scratch test to detect cell migration, a Transwell assay to measure cell invasion, and a flow cytometry to analyze cell apoptosis. Results: The expression level of miR-135a was lower while those of IGF-1, PI3K and Akt mRNA were higher in NSCLC tissues than in the adjacent normal tissues. Dual-luciferase reporter assay indicated IGF-1 as a target of miR-135a. The in vitro results showed that compared with the blank group, cell proliferation, migration and invasion were suppressed, mRNA and protein levels of IGF-1, PI3K, Akt, VEGF, bFGF and IL-8 were reduced, and cell apoptosis was enhanced in the miR-135a mimics and IGF-1 siRNA groups. Compared with the IGF-1 siRNA group, cells in the miR-135a inhibitors + IGF-1 siRNA group demonstrated increased cell proliferation, migration and invasion, elevated mRNA and protein levels of IGF-1, PI3K, Akt, VEGF, bFGF and IL-8 and reduced cell apoptosis. Conclusion: These findings indicated that miR-135a promotes cell apoptosis and inhibits cell proliferation, migration, invasion and tumor angiogenesis by targeting IGF-1 gene through the IGF-1/PI3K/Akt signaling pathway in NSCLC.

The Novel Mir-9501 Inhibits Cell Proliferation, Migration and Activates Apoptosis in Non-Small Cell Lung Cancer

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.

Identification of Microrna-615-3p As a Novel Tumor Suppressor in Non-Small Cell Lung Cancer.

miR-215 suppresses proliferation and migration of non-small cell lung cancer cells.

Mir-1225-5p Inhibits Non-Small Cell Lung Cancer Cell Proliferation, Migration and Invasion, and May Be a Prognostic Biomarker.

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer

Overexpression of mir-489-3p inhibits proliferation and migration of non-small cell lung cancer cells by suppressing the HER2/PI3K/AKT/Snail signaling pathway

Mir-194 Inhibits the Proliferation, Invasion, Migration, and Enhances the Chemosensitivity of Non-Small Cell Lung Cancer Cells by Targeting Forkhead Box A1 Protein

Microrna-99A is Downregulated and Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer A549 and H1299 Cells.

MiR-181a-5p Inhibits Cell Proliferation and Migration by Targeting Kras in Non-Small Cell Lung Cancer A549 Cells

Mir-145 Suppresses the Proliferation, Invasion and Migration of NSCLC Cells by Regulating the BAX/BCL-2 Ratio and the Caspase-3 Cascade

Expression and Effect of Mir-769-5p on Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer

The Novel Mir-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non–small-cell Lung Cancer Through Altering STAT3 Expression

Mir-593-5p Inhibit Cell Proliferation by Targeting PLK1 in Non Small Cell Lung Cancer Cells

Mir-497-5p Inhibits Tumor Cell Growth and Invasion by Targeting SOX5 in Non-Small-cell Lung Cancer

Inhibition of the Growth of Non-Small Cell Lung Cancer by Mirna-1271